Cytotoxic effects of kainate ligands on HEK cell lines expressing recombinant kainate receptors

Brain Research

Volumn 720, Issue 1-2, 1996, Pages 69-74

  Carver, Jeffrey M ^a   Mansson, P Erik ^a   Cortes Burgos, Luz ^a   Shu, Joanne ^a   Zhou, Li Ming ^a   Howe, James R ^b   Giordano, Tony ^a  

^a Symphony Pharmaceuticals   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GluR6; Kainate; NBQX; SYM2081; Toxicity

Indexed keywords

4 METHYLGLUTAMIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029977515     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00115-1     Document Type: Article

References (34)

1. Beal, M.F., Mechanisms of excitotoxicity in neurologic disease, FASEB J., 6 (1992) 3338-3344.
2. Bettler, B. and Mulle, C., Review: neurotransmitter receptors. II. AMPA and kainate receptors, Neuropharmacology, 34 (1995) 123-139.
3. Boulter, J., Hollmann, M., O'Shea-Greenfield, A., Hartley, M., Deneris, E., Maron, C. and Heinemann, S., Molecular cloning and functional expression of glutamate receptor subunit genes, Science, 249 (1990) 1033-1037.
4. Brorson, J.R., Manzolillo, P.A., Gibbons, S.J. and Miller, R.J., AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity, J. Neurosci., 15 (1995) 4515-4524.
5. Cai, N.-S. and Erdo, S.L., The effects of kainate and the glutamate agonist, AMPA, are not separable in rat neocortical cultures, Neurosci. Lett., 141 (1992) 57-60.
6. Choi, D.W., Ionic dependence of glutamate neurotoxicity in cortical cell culture. J. Neurosci., 7 (1987) 369-379.
7. Choi, D.W., Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage, Trends Neurosci., 11 (1988) 465-469.
8. Choi, D.W., Koh, J.Y. and Peter, S., Pharmacology of glutamate neurotoxicity in cortical cultures: attenuation by NMDA antagonists, J. Neurosci., 8 (1988) 185-196.
9. Coyle. J.T., Neurotoxic action of kainic acid, J. Neurochem., 41 (1983) 1-11.
10. Denizot, F. and Lang, R., Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J. Immunol. Methods, 89 (1986) 271-277.
11. 2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6, Proc. Natl. Acad. Sci. USA, 90 (1993) 755-759.
12. Gu, Z.-Q., Hesson, D.P., Pelletier, J.C., Maccecchini, M.-L., Zhou, L.-M. and Skolnick, P., Synthesis, resolution, and biological evaluation of the four stereoisomers of 4-methylglutamic acid: selective probes of kainate receptors, J. Med. Chem., 38 (1995) 2518-2520.
13. Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W. and Seeburg, P.H., The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits, Neuron, 8 (1992) 775-785.
14. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition, Science, 252 (1991) 851-853.
15. Hollmann, M., Hartley, M. and Heinemann, S., Cloned glutamate receptors, Annu. Rev. Neurosci., 17 (1994) 31-108.
16. Howe, J.R., Skryabin, B.V., Belcher, S.M. and Zerillo, C.A., Schmauss, C., The responsiveness of a tetracycline-sensitive expression system differs in different cell lines, J. Biol. Chem., 270 (1995) 14168-14174.
17. Howe, J.R., Homomeric and heteromeric ion channels formed from the kainate-type subunits GluR6 and KA2 have very small, but different, unitary conductances, J. Neurophysiol., in press..
18. Kaku, D.A., Goldberg, M.P. and Choi, D.W., Antagonism of non-NMDA receptors augment the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose, Brain Res., 554 (1991) 344-347.
19. Kato, K., Puttfarcken, P.S., Lyons, W.E. and Coyle, J.T., Developmental time course and ionic dependence of kainate-mediated toxicity in rat cerebellar granule cell cultures, J. Pharmacol. Exp. Ther., 256 (1991) 402-411.
20. Koh, J.Y., Goldberg, M.P., Hartley, D.M. and Choi, D.W., Non-NMDA receptor-mediated neurotoxicity in cortical culture, J. Neurosci., 10 (1990) 693-705.
21. Koh, J. and Choi, D.W., Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay, J. Neurosci. Methods, 20 (1987) 83-90.
22. Koh, J.-Y. and Choi, D.W., Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death, Brain Res., 548 (1991) 318-321.
23. Mayer, M.L., MacDermott, A.B., Westbrook, G.L., Smith, S.J. and Barker, J.L., Agonist-and voltage-gated calcium entry in cultured mouse spinal cord neurons under voltage clamp measured using arsenazo-III, J. Neurosci., 7 (1987) 3230-3244.
24. Nakanishi, N., Shneider, N.A. and Axel, R., A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties, Neuron, 5 (1990) 569-581.
25. Nakanishi, S., Molecular diversity of glutamate receptors and implications for brain function, Science, 258 (1992) 597-603.
26. Prehn, J.H.M., Lippert, K. and Krieglstein, J., Are NMDA or AMPA/kainate receptor antagonists more efficacious in delayed treatment of excitotoxic neuronal injury?, Eur. J. Pharmacol., 292 (1995) 179-189.
27. Regan, R.F. and Choi, D.W., The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture, Brain Res., 633 (1994) 236-242.
28. Rosenberg, P.A. and Aizenman, E., Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex, Neurosci. Lett., 103 (1989) 162-168.
29. Rothman, S.M., Thurston, J.H. and Hauhart, R.E., Delayed neurotoxicity of excitotoxic amino acids in vitro, Neuroscience, 22 (1987) 472-480.
30. Sheardown, M.J., Nielson, E.O., Hansen, A.J., Jacobson, P. and Honore, T., 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia, Science, 247 (1990) 571-574.
31. Stein, E., Cox, J.A., Seeburg, P.H. and Verdoorn, T.A., Complex pharmacological properties of recombinant α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes, Mol. Pharmacol., 42 (1992) 864-871.
32. Tygeson, C.K., Rasmussen, J.S., Jones, S.V.P., Hansen, A., Hansen, K. and Anderson, P.H., Stable expression of a functional GluR6 homomeric glutamate receptor channel in mammalian cells, Proc. Natl. Acad. Sci. USA, 91 (1994) 13018-13022.
33. Yoshioka, A., Hardy, M., Younkin, D.P., Grinspan, J.B., Stern, J.L. and Pleasure, D., Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate cytotoxicity in the oligodendroglial lineage, J. Neuorchem., 64 (1995) 2442-2448.
34. Zhou, L.-M., Gu, F.-Q., Costa, A.M., Yamada, K.A., Mansson, P.-E., Giordano, T., Skolnick, P. and Jones, K., (2S,4R)-4-Methyl-Glutamic Acid (SYM2081): A potent, selective probe for kainate receptors, submitted.